排序方式: 共有4条查询结果,搜索用时 46 毫秒
1
1.
2.
单克隆抗体SZ-2特异作用于人血小板和巨核细胞,测定10例正常人血小板SZ-2结合位点数为15200±4100/血小板,KD值0.66±0.33nM。SZ-2所识别的抗原对糜蛋白酶敏感,但对神经氨酸酶不敏感,亲和层析技术证明其为血小板糖蛋白Ib(GPIb)。SZ-2与其它抗GPIb单克隆抗体不同,它不仅抑制瑞斯托霉素诱导的血小板聚集,而且也抑制Ⅰ型胶原和血小板活化因子诱导的血小板聚集,并抑制上述诱导剂引起的血小板5-HT和βTG释放。 相似文献
3.
The B-chain of urokinase (UK) was covalently linked by disulfide bond to the Fab fragment of an anti-human activated platelet monoclonal antibody(SZ-51). The UKSZ-51 conjugate retained the original binding specificity of its parent antibody, and produced about a 5-fold enhancement in clot lysis in plasma over that of the urokinase in vitro. Whereas UK significantly decreased the concentration of fibrinogen in plasma clot assay supernatants, UK-SZ-51 did not. 相似文献
4.
A monocloual antibody, SZ-2, reacts specifically on human platelets and megakaryocytes. The plate-lets from 10 normal donors are bound to 15,200±4,100 SZ-2 molecules/platelet. The antigen recognizedby SZ-2 is chymotrypsin-sensitive but neuraminidase-insensitive, and has been identified as glycoproteinIb (GPIb) by an affinity chromatography technique. SZ-2 is different from other monoclonal antibodiesto GPIb. It inhibits not only platelet aggregation induced by ristocetin, but also platelet aggregation in-duced by collagen (type Ⅰ) and by PAF. SZ-2 also inhibits platelet serotonin and β-thromboglobulinrelease in response to these stimuli. 相似文献
1